FL2-10262-88502
2 vaccinations
4 coded responses
23 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 208 / MD
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Dose 1 — Moderna
-
2021-04-10
Registered in v-safe
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity — Feeling: GoodFree text: This is day 3 after the shot. No symptoms at all except moderate soreness in the arm on the day of which resolved by the following morning.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
-
2021-05-05
Dose 2 — Moderna
- 2021-05-05
-
2021-05-06
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Soreness at injection site is some where between mild and moderate, identical to 1st dose symptom.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Tenderness — Feeling: Good · Site: PainFree text: Soreness/tenderness in underarm where shot was administered.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-06-16
- 2021-08-04
-
2021-11-03
Survey response — 6 months, dose 2MedDRA: Unevaluable event — Feeling: GoodFree text: Menstrual changes possibly, began menopause about 6-12 months previously and recently saw some return of periods shortly after starting very low dose of hrt for menopause symptoms. Did not suspect the cax until reading some reports of similar exper.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Moderna | |
| 2 | 2021-05-05 | Moderna |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): This is day 3 after the shot. No symptoms at all except moderate soreness in the arm on the day of which resolved by the following morning.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Soreness at injection site is some where between mild and moderate, identical to 1st dose symptom.
Systemic reaction (other): Soreness/tenderness in underarm where shot was administered.
Release 10 — 6 months, dose 2
Symptoms: Menstrual changes possibly, began menopause about 6-12 months previously and recently saw some return of periods shortly after starting very low dose of hrt for menopause symptoms. Did not suspect the cax until reading some reports of similar exper. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Unevaluable event | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release